Tendler B E, Shoukri K, Malchoff C, MacGillivray D, Duckrow R, Talmadge T, Ramsby G R
Division of Endocrinology, University of Connecticut Health Center, Farmington, USA.
Thyroid. 1997 Aug;7(4):625-9. doi: 10.1089/thy.1997.7.625.
We describe two Caucasian women with the concurrence of Graves' disease and the moyamoya phenomenon (radiological evidence of collateral cerebral blood vessels like "puffs of smoke" due to cerebrovascular occlusive disease). One patient presented with acute cerebrovascular ischemia due to Moyamoya disease shortly after radioactive iodine therapy for Graves' disease and the second presented with Graves' disease 10 years after being diagnosed with moyamoya dysplastic cerebral vessels. The optimal treatment of hyperthyroidism in these patients is unknown; however, careful control of the hyperthyroidism by any modality seems reasonable. Our limited experience suggests that antithyroid drugs and radioactive iodine therapy are rational options. Thyroidectomy appears to be a safe therapeutic alternative, although long-term efficacy may be difficult to assure. Both of our patients had to be treated twice for hyperthyroidism. Whether Graves' disease and Moyamoya coexist because of an aggressive autoimmune mechanism is a concept that remains to be settled.
我们描述了两名患有格雷夫斯病(Graves' disease)并伴有烟雾病现象(由于脑血管闭塞性疾病导致脑侧支血管出现“烟雾状”的放射学证据)的白种女性。一名患者在接受格雷夫斯病放射性碘治疗后不久因烟雾病出现急性脑血管缺血,另一名患者在被诊断为烟雾病发育异常脑血管10年后出现格雷夫斯病。这些患者甲状腺功能亢进的最佳治疗方法尚不清楚;然而,通过任何方式仔细控制甲状腺功能亢进似乎是合理的。我们有限的经验表明,抗甲状腺药物和放射性碘治疗是合理的选择。甲状腺切除术似乎是一种安全的治疗选择,尽管长期疗效可能难以保证。我们的两名患者都因甲状腺功能亢进而接受了两次治疗。格雷夫斯病和烟雾病是否由于积极的自身免疫机制而共存仍是一个有待解决的问题。